BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2077186)

  • 21. Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea-pig and platelet aggregation in man.
    Evans TW; Dent G; Rogers DF; Aursudkij B; Chung KF; Barnes PJ
    Br J Pharmacol; 1988 May; 94(1):164-8. PubMed ID: 3401633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diesel exhaust particulates induce nasal mucosal hyperresponsiveness to inhaled histamine aerosol.
    Kobayashi T; Ito T
    Fundam Appl Toxicol; 1995 Sep; 27(2):195-202. PubMed ID: 8529814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of thromboxane A2 and peptide leukotrienes in early and late phase nasal blockage in a guinea pig model of allergic rhinitis.
    Yamasaki M; Mizutani N; Sasaki K; Nabe T; Matsumoto T; Ashida Y; Kohno S
    Inflamm Res; 2001 Sep; 50(9):466-73. PubMed ID: 11603852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desloratadine citrate disodium injection, a potent histamine H(1) receptor antagonist, inhibits chemokine production in ovalbumin-induced allergic rhinitis guinea pig model and histamine-induced human nasal epithelial cells via inhibiting the ERK1/2 and NF-kappa B signal cascades.
    Chen M; Xu S; Zhou P; He G; Jie Q; Wu Y
    Eur J Pharmacol; 2015 Nov; 767():98-107. PubMed ID: 26455479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of thromboxane A2 in airway microvascular leakage induced by inhaled platelet-activating factor.
    Tokuyama K; Lötvall JO; Morikawa A; Barnes PJ; Chung KF
    J Appl Physiol (1985); 1991 Nov; 71(5):1729-34. PubMed ID: 1837014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
    Hwang SB; Li CL; Lam MH; Shen TY
    Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of flutropium on experimental models of drug- and allergy-induced rhinitis in guinea pigs.
    Mizuno H; Kawamura Y; Iwase N; Ohno H
    Jpn J Pharmacol; 1991 Mar; 55(3):321-8. PubMed ID: 1677436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of anti-PAF and other agents on the nasal symptoms in sensitized guinea pigs.
    Narita S; Asakura K
    Auris Nasus Larynx; 1993; 20(3):175-83. PubMed ID: 7905260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of platelet activating factor (PAF) in histamine-induced model of nasal allergy in rats.
    Akagi M; Kanoh R; Fukuishi N; Tachibana M; Akagi R
    Arerugi; 1995 Mar; 44(3 Pt 1):182-8. PubMed ID: 7646374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of airway narrowing caused by inhaled platelet-activating factor. Role of airway microvascular leakage.
    Tokuyama K; Lötvall JO; Barnes PJ; Chung KF
    Am Rev Respir Dis; 1991 Jun; 143(6):1345-9. PubMed ID: 2048823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of NK1 receptor antagonists (FK224 and FK888) on agonist- and antigen-induced nasal microvascular leakage in guinea pigs.
    Shirasaki H; Asakura K; Narita S; Watanabe M; Kataura A
    Inflamm Res; 1997 Jan; 46(1):28-31. PubMed ID: 9117514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory mediators involved in antigen-induced airway microvascular leakage in guinea pigs.
    Evans TW; Rogers DF; Aursudkij B; Chung KF; Barnes PJ
    Am Rev Respir Dis; 1988 Aug; 138(2):395-9. PubMed ID: 2848429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet-activating factor (PAF) plays an important role in the immediate asthmatic response in guinea-pig by augmenting the response to histamine.
    Morooka S; Uchida M; Imanishi N
    Br J Pharmacol; 1992 Mar; 105(3):756-62. PubMed ID: 1628161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of platelet-activating factor on histamine hypersensitivity in nasal allergy in guinea pig models.
    Narita S; Asakura K
    Int Arch Allergy Immunol; 1993; 100(4):373-7. PubMed ID: 7683226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rolipram inhibits airway microvascular leakage induced by platelet-activating factor, histamine and bradykinin in guinea-pigs.
    Ortiz JL; Cortijo J; Vallés JM; Bou J; Morcillo EJ
    J Pharm Pharmacol; 1993 Dec; 45(12):1090-2. PubMed ID: 7908981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo.
    Hirayama Y; Lei YH; Barnes PJ; Rogers DF
    Br J Pharmacol; 1993 Mar; 108(3):844-51. PubMed ID: 7682142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Hoe 140, a new bradykinin receptor antagonist, on bradykinin- and platelet-activating factor-induced bronchoconstriction and airway microvascular leakage in guinea pig.
    Sakamoto T; Elwood W; Barnes PJ; Chung KF
    Eur J Pharmacol; 1992 Mar; 213(3):367-73. PubMed ID: 1319919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet activating factor degradation in tear fluid from guinea pigs with allergic conjunctivitis.
    Kato M; Mano H; Ota A; Konomi K; Nakata K
    J Ocul Pharmacol Ther; 2001 Feb; 17(1):83-91. PubMed ID: 11327052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of platelet-activating factor on airway vascular permeability: possible mechanisms.
    Evans TW; Chung KF; Rogers DF; Barnes PJ
    J Appl Physiol (1985); 1987 Aug; 63(2):479-84. PubMed ID: 3115939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.